Separate a cosmetic claim from a prescription offer
FDA states that over-the-counter skin-lightening products containing hydroquinone are not approved for sale in the United States. Its consumer guidance distinguishes those listings from a prescription skin product obtained through a healthcare provider. Mercury-containing skin-lightening products are a separate prohibited and hazardous category.
A listing can use words such as brightening, fading or evening without making its contents clearer. Read the complete product identity and label, not only the headline. If hydroquinone appears in a no-prescription offer, the existence of a payment button does not resolve the regulatory problem. Our prescription guide explains the distinctions.
A prescription also does not automatically make a finished product FDA-approved. Compounded preparations and specific manufactured drugs have their own evidence and status. Ask the prescriber or pharmacist about the proposed product rather than interpreting a familiar ingredient name as a universal approval mark.
Read a complete label while recognizing its limits
FDA lists mercury names that may appear on labels, including mercurous chloride, calomel, mercuric, mercurio and Hg. It also warns that some illegal products do not declare hydroquinone or mercury. A label that omits those words therefore cannot function as a laboratory certificate proving their absence.
For a US purchase, obtain complete English labeling as well as any other languages provided. A multilingual package is not itself a defect. The practical problem is missing, incomplete or unreadable information that prevents you and a health professional from identifying the product and its contents.
Keep clear images of the front, ingredient panel, manufacturer or distributor details and lot markings. Save the seller's identity and order record separately. Do not rely on a cropped marketplace photo as a substitute for the delivered container. If the two differ, that discrepancy is worth resolving before making assumptions about the product.
Use FDA's tested-product table for the question it answers
The agency maintains a table naming particular skin-lightening products tested by its laboratories. The version we reviewed includes 2026 entries as well as older ones, with seller details, measured substances and recall or marketplace status where provided. The date accessed and the year tested are different pieces of information.
Match the name and seller carefully when checking a concern. A similar package color or a shared marketing phrase is not a reliable identity match. Conversely, failure to find a name in that table is not evidence that FDA has tested and cleared it. The table is a record of specified findings, not a complete inventory of every product offered online.
We have not used the table to accuse CoreAge Rx, Obagi or another reviewed provider of contamination. Those would require findings about the specific product. The methodology page explains how this publication separates a regulatory warning, an advertised formula and evidence about a named preparation.
Check the dispensing organization independently
For an online prescription, identify the pharmacy that would actually dispense the medicine. FDA's BeSafeRx resource links state-board license databases and advises checking for a prescription requirement, a US physical address and phone number, and access to a licensed pharmacist. The platform's brand name may not be the dispenser's legal name.
Use the board's own database rather than a license image pasted into a sales page. Ask for clarification if the name or address does not match. Our publication has not audited every pharmacy that a platform might use, and a review of public terms should not be mistaken for that work.
Keep the same standard for the sponsor. The CoreAge Rx review records the public Spot On offer and the details still to confirm. Common commercial ownership is disclosed; it does not replace verification of the actual prescription, dispenser or care arrangements.
If mercury exposure is a concern, seek qualified advice
FDA explains that mercury exposure can affect people using the product and others in the household through contaminated items or vapors. It advises stopping use of a mercury-containing product, washing exposed skin and contacting a healthcare professional. This is not something a home patch test can rule out.
The US Poison Center is available at 1-800-222-1222 for exposure questions. Seek emergency help for severe symptoms. A symptom list on a website cannot confirm poisoning or exclude it, and a consumer supplement sold as a detox should not substitute for assessment.
For a product that may contain mercury, FDA advises sealing it in a plastic bag or leak-proof container and asking the local environmental, health or solid-waste agency how to dispose of it. Keep identifying information for the care team; do not mail an opened suspect product to a review publisher or treat routine cosmetic returns as disposal instructions.
Record a concern without deciding the cause yourself
When speaking with a clinician, describe the product, the area of use, the timing and what changed. Report other products used during the same period. A rash or pigment change may need assessment even when the ingredient responsible has not been identified. Our irritation guide and photograph guide can help organize the account.
FDA accepts adverse-event reports through MedWatch. Reporting can preserve information for safety monitoring; it does not deliver immediate clinical care or prove causation. Avoid posting medical photographs, addresses or prescription details in public customer reviews when a secure clinical channel is available.
The useful outcome of checking a label is a clearer next decision: identify the product, resolve missing information, seek professional advice where needed and retain the right records. It is not a green badge that makes an unknown cream safe, nor a reason to assume every prescription or cosmetic in the same broad category has the same risks.